✦ LIBER ✦

Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme

✍ Scribed by Xin-Lin Mu; Long-Yun Li; Xiao-Tong Zhang; Shu-Lan Wang; Meng-Zhao Wang

Book ID: 115010581
Publisher: BioMed Central
Year: 2004
Tongue: English
Weight: 293 KB
Volume: 4
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-4-51

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-587 Experience from a large multi-cent

P-587 Experience from a large multi-centre expanded access programme (EAP) with gefitinib (‘Iressa’, ZD1839) as monotherapy in advanced non-small cell lung cancer (NSCLC)

✍ van Puijenbroek, R.; Bosquée, L.; Tits, G.; Germonpre, P.; Strobbe, E.; Vansteen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Evaluation of efficacy and safety of gef

Evaluation of efficacy and safety of gefitinib as monotherapy in Chinese patients with advanced non-small cell lung cancer and very poor performance status

✍ Zhong Wei; Wang Mengzhao; Zhang Li; Li Longyun; Zhang Xiaotong 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 224 KB

P-624 A pilot trial of gefitinib (‘Iress

P-624 A pilot trial of gefitinib (‘Iressa’, ZD1839) in combination with docetaxel in patients with advanced or metastatic non-small-cell lung cancer: safety results

✍ Manegold, C.; Gatzemeier, U.; Buchhoiz, E.; Smith, R.; Averbuch, S.; Fandi, A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Dramatic effect of ZD1839 (‘Iressa’) in

Dramatic effect of ZD1839 (‘Iressa’) in a patient with advanced non-small-cell lung cancer and poor performance status

✍ Fujiwara, Keiichi; Kiura, Katsuyuki; Ueoka, Hiroshi; Tabata, Masahiro; Hamasaki, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Efficacy of gefitinib as a first-line si

Efficacy of gefitinib as a first-line single agent treatment in patients with advanced non-small cell lung cancer

✍ Yin, Yongmei; Geng, Yiting; Li, Xiaodong; Hu, Xiaoli; Chen, Xiaofeng; Li, Wei; S 📂 Article 📅 2009 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 490 KB

ZD1839, a novel, oral epidermal growth f

ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program

✍ Pallis, A.G.; Mavroudis, D.; Androulakis, N.; Souglakos, J.; Kouroussis, C.; Boz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 195 KB